drugset / Trial / NCT01326546
Therapeutic Hepatitis B Vaccine (Mimogen-based) Joint Entecavir in Treating Chronic Hepatitis B Patients
Phase 2
Completed
378 enrolled
Chongqing Jiachen Biotechnology Ltd.
Third Military Medical University · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose is to evaluate efficacy and safety of therapeutic hepatitis B virus (HBV) vaccine (mimogen-based)) Joint entecavir treatment in chronic hepatitis B patients.
Timeline
- Start
- 2010-06
- Primary completion
- 2014-01
- Completion
- 2014-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Entecavir | Small molecule | 0.5 mg | Oral |
| Subject | εPA-44 | Vaccine | 900 ug | — |